Clinical Trials Directory

Trials / Unknown

UnknownNCT02884739

Mental Healthcare in Older Adults With Schizophrenia

The Mortality and Its Associated Factors in Schizophrenia Patients Older Than 60 Years

Status
Unknown
Phase
Study type
Observational
Enrollment
685 (actual)
Sponsor
CHU de Reims · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

As in the general population, there is a gradual and steady increase in life expectancy of patients with schizophrenia. But this increase is at a smaller scale, with a rate of premature death that is still 2 to 3 times higher than that found in the general population. This excessive early mortality is explained by an overrepresentation of suicide deaths, but also a higher prevalence of somatic diseases, mainly cardiovascular. But today there are only very few epidemiological data on the mortality of patients with schizophrenia, including those aged over 60 years. What are the sociodemographic and clinical characteristics (psychiatric and somatic) of these schizophrenic elderly patients? Do they benefit from a somatic follow-up adequate and systematic? What are their levels of social independence and of quality of life? the answers these questions and the description of the offer of geriatric care and of psychiatric care currently provided by different sectors of psychiatry in France is an indispensable prerequisite for any project to improve the quality of life, state of health and mortality of older patients with schizophrenia.

Detailed description

Evaluate prospectively over 5 years, the rates and causes of mortality in a cohort of schizophrenic patients older than 60 years, followed by adult psychiatry sectors, compared to those patients matched for sex and age and monitored by the same sectors for a chronic psychiatric disorder other than schizophrenia

Conditions

Interventions

TypeNameDescription
OTHERData collection

Timeline

Start date
2010-01-01
Primary completion
2018-07-01
Completion
2018-07-01
First posted
2016-08-31
Last updated
2016-09-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02884739. Inclusion in this directory is not an endorsement.